← FDA Drug Approvals (Drugs@FDA)
INDOMETHACIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2014-03-20
Drug application
- FDA Application #
ANDA202139- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- INDOMETHACIN
- Generic name
- Indomethacin
- Active ingredients
- INDOMETHACIN
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- MYLAN
- First approval
- 2014-03-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown